ArticleHypertension research : official journal of the Japanese Society of Hypertension2026
Validation of ring-type cuffless blood pressure (BP) monitoring device for detecting awake-asleep BP variations compared to ambulatory BP monitoring device.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Is phosphate burden an under-recognized driver of apparent treatment-resistant hypertension in CKD?Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Highlights of the 2026 Korean Society of Hypertension guidelines for the management of hypertension: what's new and what has changed.Clinical hypertension · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We evaluated the accuracy of a ring-type cuffless BP device (CART BP Pro) in detecting awake-asleep BP changes compared to conventional 24-h ambulatory BP monitoring (ABPM), following the validation protocol recommended by the European Society of Hypertension (ESH). Among 84 recruited patients, 35 were selected to satisfy ESH recommendations: 30% (n = 11) with systolic BP (SBP) ≥ 130 mmHg and diastolic BP (DBP) ≥ 80 mmHg and 30% (n = 11) with SBP < 120 mmHg and DBP < 70 mmHg. The remaining 40% (n = 13) were included sequentially based on recruitment order. CART BP Pro was calibrated at least one day prior to simultaneous monitoring with ABPM. Participants simultaneously wore both devices on the non-dominant arm for 24 h. Mean SBP/DBP values and awake-asleep BP changes were compared. Awake-asleep SBP/DBP changes were 15.61 ± 8.74/11.35 ± 6.22 mmHg (ABPM) and 13.87 ± 9.04/11.44 ± 8.62 mmHg (CART BP Pro). Differences in mean awake-asleep BP changes were -1.74 ± 6.47 mmHg (SBP) and 0.08 ± 5.84 mmHg (DBP). Correlation analysis showed clinically significant correlation for both SBP and DBP changes (r = 0.736, p < 0.01). Bland-Altman plots showed acceptable agreement with a mean difference and 95% limits of agreement of -1.74 (-14.42, 10.94) mmHg for SBP and 0.08 (-11.37, 11.53) mmHg for DBP. For four-category dipping classification, CART BP Pro showed moderate agreement with ABPM (weighted κ = 0.58). In conclusion, CART BP Pro showed a meaningful level of agreement with ABPM in detecting awake-asleep BP changes. As this addressed only the awake/asleep test of the ESH protocol, the device cannot yet replace conventional 24-h ABPM pending completion of the remaining validation tests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.